Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

InvestigationalNo placebo

Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Belantamab Mafodotin
Sponsor:Hellenic Society Of Hematology

Contact Research Centre

Rheumatoid arthritis

Recruiting

Study on Adjusting Tocilizumab Doses for Patients with Rheumatoid Arthritis

Registered drugNo placebo

Study on Adjusting Tocilizumab Doses for Patients with Rheumatoid Arthritis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Reade revalidatie & reumatologie centrum te Amsterdam

Contact Research Centre

Immune thrombocytopenia

Recruiting

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Efgartigimod Alfa
Sponsor:Argenx

Contact Research Centre

Substances studied in this area

The therapies tested most often in Immune system disorders trials.

Sodium Chloride61 clinical trials Rituximab50 clinical trials Prednisone47 clinical trials Adalimumab40 clinical trials Emtricitabine39 clinical trials Tocilizumab38 clinical trials Tenofovir Alafenamide37 clinical trials Methotrexate36 clinical trials Prednisolone35 clinical trials

Immune system disorders – page 24

Conditions in this area

Clinical trials in Immune system disorders

1 641 clinical trials

Axial spondyloarthritis+1

Study on the Effects of Sonelokimab in Patients with Active Psoriatic Arthritis or Axial Spondyloarthritis

Haemophagocytic lymphohistiocytosis

A study of ruxolitinib as first treatment for children with haemophagocytic lymphohistiocytosis (HLH)

Asthma

Study on Stopping Dupilumab in Patients with Severe Asthma Who Have Been on the Drug for Over 3 Years

Still's disease+1

Study on the Effectiveness and Safety of Deucravacitinib for Children and Teens with Juvenile Psoriatic Arthritis

Dermatomyositis+2

Study on the Long-Term Safety of Dazukibart in Patients with Idiopathic Inflammatory Myopathies, Including Dermatomyositis and Polymyositis

Systemic scleroderma

Study on the Safety of T-Guard (Dafsolimab Setaritox, Grisnilimab Setaritox) for Patients with Early Diffuse Cutaneous Systemic Sclerosis

Psoriasis

Study on Sodium Fluoride (18F) PET-CT Scans for Detecting Bone Changes in Psoriasis Patients at Risk of Psoriatic Arthritis

Cardiac amyloidosis

Study to Diagnose Cardiac Amyloidosis in Patients with Monoclonal Component Using Florbetaben (18F) PET-CT

Colitis ulcerative+1

Study on Reducing Vedolizumab Dosage for Patients with Inflammatory Bowel Disease

Immune thrombocytopenia

Study on the Safety and Effectiveness of Belantamab Mafodotin for Adults with Primary Immune Thrombocytopenia Previously Treated with Standard Medications

Rheumatoid arthritis

Study on Adjusting Tocilizumab Doses for Patients with Rheumatoid Arthritis

Immune thrombocytopenia

Study on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia

Filter the trials

Substances studied in this area

Prefer not to search? Our Concierge searches the trials for you.